CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
MRNA Technical Expert | Industry Canada · CanPursue
Opportunities
Fit is part of the trial and paid plans.Closed

MRNA Technical Expert

Industry CanadaISED201730Federal
Find on CanadaBuysAdd to pipeline
Published
Jan 31, 2022
Respond by
Apr 4, 2022
Latest amendment
—5 amendments

See how this opportunity fits your company

Create a free account and describe your company. With the trial, CanPursue checks every opportunity against it and explains the fit.

Create free account

Who won similar work

Create a free account to see past contracts like this one: who won and at what price.

Create free account

Description

The Government of Canada announced its Biomanufacturing and Life Sciences Strategy that identified the need for Canada to enhance its Biomanufacturing, Research and Commercialization capabilities and to be able to address production gaps that will ensure that it can respond to a range of future health threats by producing vaccines across a wide range of pathogens. Within this, Canada recognizes the criticality of ribonucleic acid (RNA) technologies, both within the context of responding to the current pandemic, as well as to enhance preparedness for a future pandemic or other health emergency. As such, the Government is interested in developing a stronger understanding regarding the optimal applications of the mRNA technologies to address current and future pandemic, or other health emergency, readiness. This state of readiness includes a detailed understanding of how best to optimize the mRNA manufacturing process, how to develop and leverage future RNA advancements, and how to best place Canada strategically so its can meet both its needs and obligations..ISED is seeking the services of an expert with knowledge in the biotechnology and biomanufacturing infrastructure sectors, who can specifically provide industry knowledge regarding the mRNA Good Manufacturing Practices (GMP) manufacturing process and who fully understands both the current and emerging RNA technologies that will supplement ISED’s current in-house knowledge. This expert will be providing critical support to Innovation, Science and Economic Development along with Other Government Departments (OGDs) on a case-by-case basis and is expected to utilize a strategic lens when providing project-related work pertaining to RNA development and production. Access to this expertise will help bolster officials’ understanding of the technology and its manufacturing opportunities along with current and future best practices. This expert will support the government’s deeper understanding of the future of the mRNA technologies as new enabling technologies and processes are applied and refined.

Procurement

Category
Services
Jurisdiction
Federal

Not stated in the notice: procurement type, procurement method, selection criteria, region of delivery, region of opportunity, expected contract period, end user

Requirements and qualifications

Supply arrangement
Not stated in the public notice
Security requirement
Not stated in the public notice
Trade agreements
—
Limited tendering reason
—

Classification

GSIN
—
UNSPSC
—

Amendments

The source reports 5 amendments. CanPursue observed 1 of them with dates.

  • Amendment 5Mar 23, 2022
  • Original noticeJan 31, 2022

Documents

No attachments listed in the open data.

Contact

No contact listed in the open data.

Related

More from this buyer

No related records observed.

Linked contracts

No related records observed.

Source

Find on CanadaBuys

CanPursue has no direct link to this notice. This opens a CanadaBuys search for its solicitation number.

Source
CanadaBuys
Solicitation
ISED201730
Observed
Sep 18, 2026

The amount, value range and contract duration shown on some CanadaBuys pages are not in the open data, so CanPursue does not show them.

Never miss an amendment

Track this opportunity in your pipeline and watchlists with a free account.

Create free account